Compare SRZN & RAAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRZN | RAAQ |
|---|---|---|
| Founded | 2015 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.3M | 240.3M |
| IPO Year | N/A | N/A |
| Metric | SRZN | RAAQ |
|---|---|---|
| Price | $26.68 | $10.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 70.3K | ★ 206.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.11 | $9.62 |
| 52 Week High | $29.60 | $10.75 |
| Indicator | SRZN | RAAQ |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 56.66 |
| Support Level | $23.63 | $10.19 |
| Resistance Level | $27.96 | $10.73 |
| Average True Range (ATR) | 2.25 | 0.10 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 51.13 | 60.02 |
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Real Asset Acquisition Corp is a blank check company.